Medical insurance catalog adjustment to be included in the new coronary pneumonia-related treatment drugs.

Medical Network August 5 - The State Administration of Medical Security has released the "2020 National Medical Insurance Drug Catalog Adjustment Work Programme (Draft for Comments)" to the public for comments.
the treatment of respiratory diseases related to xinguan pneumonia, the second batch of national selection drugs, etc. are expected to be included in the 2020 health insurance catalog proposed new drug scope.
In accordance with the "Order 1" of the National Health Insurance Administration, which came out on July 30, the Interim Measures for the Administration of Drug Use in Basic Medical Insurance, China has established a dynamic adjustment mechanism for improving the medical insurance catalogue, which is adjusted annually in principle.
the interim measures will come into effect on September 1, 2020.
draft for comments, the seven types of drugs outside the medical insurance catalogue can be included in the 2020 medical insurance catalogue proposed new drug scope, including the treatment of respiratory diseases related to new coronary pneumonia;
it is worth noting that the scope of the proposed new drugs also includes drugs (including new active ingredients, new dosage forms) approved for listing by the State Drug Administration from January 1, 2015 to December 31, 2019, in accordance with the new drug registration application process.
experts pointed out that this means that more new drugs, good medicineist is expected to be included in health insurance, speed up the protection of people's access to high-quality medical services.
, according to the draft, the price/cost is significantly higher than other drugs in the same field of treatment, and drugs that have occupied a larger amount of funds in recent years are to be included in the 2020 health insurance catalogue adjustment.
since the outbreak of new crown pneumonia, the State Health Insurance Administration issued a "two-ensure" policy, the diagnosis and suspected patients all the first treatment, after settlement.
As of July 19, the country's new crown pneumonia confirmed and suspected patients have 135,500 medical insurance settlement, involving medical expenses of 1.847 billion yuan, medical insurance payments of 1.232 billion yuan, the proportion of payment reached 67%.
experts pointed out that the adjustment of the medical insurance directory will be the new coronary pneumonia-related treatment drugs into the new scope, will provide important support for the new coronary pneumonia epidemic prevention and control of the normalization. According to the
, the 2020 health insurance catalog adjustment is divided into five stages: preparation, enterprise declaration, expert review, negotiation and bidding, publication of results.
the results will be published from November to December 2020.
.